PURETECH HEALTH Debt

0VQ Stock  EUR 1.79  0.02  1.13%   
PURETECH HEALTH PLC holds a debt-to-equity ratio of 0.138. . PURETECH HEALTH's financial risk is the risk to PURETECH HEALTH stockholders that is caused by an increase in debt.
Given that PURETECH HEALTH's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which PURETECH HEALTH is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of PURETECH HEALTH to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, PURETECH HEALTH is said to be less leveraged. If creditors hold a majority of PURETECH HEALTH's assets, the Company is said to be highly leveraged.
  
Check out the analysis of PURETECH HEALTH Fundamentals Over Time.

PURETECH HEALTH PLC Debt to Cash Allocation

Many companies such as PURETECH HEALTH, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
PURETECH HEALTH PLC has accumulated 77.59 M in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. PURETECH HEALTH PLC has a current ratio of 2.07, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist PURETECH HEALTH until it has trouble settling it off, either with new capital or with free cash flow. So, PURETECH HEALTH's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PURETECH HEALTH PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PURETECH to invest in growth at high rates of return. When we think about PURETECH HEALTH's use of debt, we should always consider it together with cash and equity.

PURETECH HEALTH Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the PURETECH HEALTH's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of PURETECH HEALTH, which in turn will lower the firm's financial flexibility.

PURETECH HEALTH Corporate Bonds Issued

Most PURETECH bonds can be classified according to their maturity, which is the date when PURETECH HEALTH PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understaning PURETECH HEALTH Use of Financial Leverage

PURETECH HEALTH's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures PURETECH HEALTH's total debt position, including all outstanding debt obligations, and compares it with PURETECH HEALTH's equity. Financial leverage can amplify the potential profits to PURETECH HEALTH's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if PURETECH HEALTH is unable to cover its debt costs.
PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PURETECH HEALTH is traded on Frankfurt Stock Exchange in Germany.
Please read more on our technical analysis page.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in PURETECH Stock

When determining whether PURETECH HEALTH PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PURETECH HEALTH's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:
Check out the analysis of PURETECH HEALTH Fundamentals Over Time.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Please note, there is a significant difference between PURETECH HEALTH's value and its price as these two are different measures arrived at by different means. Investors typically determine if PURETECH HEALTH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PURETECH HEALTH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.